Trial Profile
A retrospective trial of Dofetilide assessing discontinuation rate in patients with atrial fibrillation or flutter and ventricular tachycardia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Dofetilide (Primary)
- Indications Atrial fibrillation; Atrial flutter; Ventricular tachycardia
- Focus Adverse reactions
- 10 Feb 2016 New trial record